Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

764
Chapter | 25 Tumor Markers
Jubala , C. M. , Wojcieszyn , J. W. , Valli , V. E. , Getzy , D. M. , Fosmire , S. P. ,
Coffey , D. , Bellgrau , D. , and Modiano , J. F. ( 2005 ). CD20 expression
in normal canine B cells and in canine non-Hodgkin lymphoma . Vet.
Pathol. 42 , 468 – 476 .
Kang , S. K. , Park , N. Y. , Cho , H. S. , Shin , S. S. , Kang , M. I. , Kim , S. K. ,
Hyun , C. , Park , I. C. , Kim , J. T. , Jeong , C. , Park , S. H. , Park , S. J. ,
Jeong , J. H. , Kim , Y. J. , Ochiai , K. , Umemura , T. , and Cho , K. O.
( 2006 ). Relationship between DNA ploidy and proliferative cell
nuclear antigen index in canine hemangiopericytoma . J. Vet. Diagn.
Invest. 18 , 211 – 214 .
Karayannopoulou , M. , Koutinas , A. F. , Polizopoulou , Z. S. , Roubies , N. ,
Fytianou , A. , Saridomichelakis , M. N. , and Kaldrymidou , E. ( 2003 ).
Total serum alkaline phosphatase activity in dogs with mammary
neoplasms: a prospective study on 79 natural cases . J. Vet. Med. A
Physiol. Pathol. Clin. Med. 50 , 501 – 505 .
Kawaguchi , T. ( 2005 ). Cancer metastasis: characterization and identification
of the behavior of metastatic tumor cells and the cell adhesion
molecules, including carbohydrates . Curr. Drug Targets Cardiovasc.
Haematol. Disord. 5 , 39 – 64 .
Kelley , L. C. , and Mahaffey , E. A. ( 1998 ). Equine malignant lymphomas:
morphologic and immunohistochemical classification . Vet. Pathol.
35 , 241 – 252 .
Khanna , C. , and Helman , L. J. ( 2006 ). Molecular approaches in pediatric
oncology . Annu. Rev. Med. 57 , 83 – 97 .
Kiupel , M. , Bostock , D. , and Bergmann , V. ( 1998 ). The prognostic significance
of AgNOR counts and PCNA-positive cell counts in canine
malignant lymphomas . J. Comp. Pathol. 119 , 407 – 418 .
Kiupel , M. , Teske , E. , and Bostock , D. ( 1999 ). Prognostic factors for
treated canine malignant lymphoma . Vet. Pathol. 36 , 292 – 300 .
Koenig , A. , Wojcieszyn , J. , Weeks , B. R. , and Modiano , J. F. ( 2001 ).
Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven
canine melanoma cell lines and twenty-nine retrospective cases of
canine melanoma . Vet. Pathol. 38 , 427 – 435 .
Koenig , A. , Bianco , S. R. , Fosmire , S. , Wojcieszyn , J. , and Modiano , J. F.
( 2002 ). Expression and significance of p53, rb, p21/waf-1, p16/ink-4a,
and PTEN tumor suppressors in canine melanoma . Vet. Pathol. 39 ,
458 – 472 .
Kuntz , C. A. , Dernell , W. S. , Powers , B. E. , Devitt , C. , Straw , R. C. , and
Withrow , S. J. ( 1997 ). Prognostic factors for surgical treatment of
soft-tissue sarcomas in dogs: 75 cases (1986–1996) . J. Am. Vet. Med.
Assoc. 211 , 1147 – 1151 .
Laprie , C. , Abadie , J. , Amardeilh , M. F. , Net , J. L. , Lagadic , M. , and
Delverdier , M. ( 2001 ). MIB-1 immunoreactivity correlates with biologic
behaviour in canine cutaneous melanoma . Vet. Dermatol. 12 ,
139 – 147 .
Lautzenhiser , S. J. , Walker , M. C. , and Goring , R. L. ( 2003 ). Unusual
IgM-secreting multiple myeloma in a dog . J. Am. Vet. Med. Assoc.
223 ( 636 ) , 645 – 648 .
Lechowski , R. , Jagielski , D. , Moffmann-Jagielska , M. , Zmudzka , M. , and
Winnicka , A. ( 2002 ). Alpha-fetoprotein in canine multicentric lymphoma
. Vet. Res. Comm. 26 , 285 – 296 .
Lee , C. H. , Kim , W. H. , Lim , J. H. , Kang , M. S. , Kim , D. Y. , and Kweon , O. K.
(2004 ). Mutation and overexpression of p53 as a prognostic factor in
canine mammary tumors . J. Vet. Sci. 5 , 63 – 69 .
Lee , J. J. , Hughes , C. S. , Fine , R. L. , and Page , R. L. ( 1996 ). P-glycoprotein
expression in canine lymphoma: a relevant, intermediate model of
multidrug resistance . Cancer 77 , 1892 – 1898 .
LeRoy , B. E. , Nadella , M. V. , Toribio , R. E. , Leav , I. , and Rosol , T. J.
( 2004 ). Canine prostate carcinomas express markers of urothelial and
prostatic differentiation . Vet. Pathol. 41 , 131 – 140 .
Letelier , L. M. , Weaver , B. , and Montori , V. ( 2002 ). Diagnosis: examples
of likelihood ratios . In “ Users ’ Guide to the Medical Literature:
A Manual for Evidence-Based Practice ” ( G. Guyatt and D. Rennie ,
Eds.) , pp. 485 – 515 . AMA Press , Chicago .
Liao , A. T. , Chien , M. B. , Shenoy , N. , Mendel , D. B. , McMahon , G. ,
Cherrington , J. M. , and London , C. A. ( 2002 ). Inhibition of
constituitively active forms of mutant kit by multitargeted indolinone
tyrosine kinase inhibitors . Blood 100 , 585 – 593 .
Lipsitz , D. , Higgins , R. J. , Kortz , G. D. , Dickinson , P. J. , Bollen , A. W. ,
Naydan , D. K. , and LeCouteur , R. A. ( 2003 ). Glioblastoma multiforme:
clinical findings, magnetic resonance imaging, and pathology
in five dogs . Vet. Pathol. 40 , 659 – 669 .
Lohr , C. V. , Teifke , J. P. , Failing , K. , and Weiss , E. ( 1997 ).
Characterization of the proliferation state in canine mammary tumors
by the standardized AgNOR method with postfixation and immunohistologic
detection of Ki-67 and PCNA . Vet. Pathol. 34 , 212 – 221 .
London , C. A. , Galli , S. J. , Yuuki , T. , Hu , Z.-Q. , Helfand , S. C. , and
Geissler , E. N. ( 1999 ). Spontaneous canine mast cell tumors express
tandem duplications in the proto-oncogene c-kit . Exp. Hematol. 27 ,
689 – 697 .
London , C. A. , Hannah , A. L. , Zadovoskaya , R. , Chien , M. B. ,
Kollias-Baker , C. , Rosenberg , M. , Downing , S. , Post , G. , Boucher , J. ,
Shenoy , N. , Mendel , D. B. , McMahon , G. , and Cherrington , J. M.
( 2003 ). Phase I dose-escalating study of SU11654, a small molecule
receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies
. Clin. Cancer Res. 9 , 2755 – 2768 .
Loste , A. , Marca , M. C. , Perez , M. , and Unzueta , A. ( 2001 ). Clinical
value of fructosamine measurements in non-healthy dogs . Vet. Res.
Commun. 25 , 109 – 115 .
Lowseth , L. A. , Gillett , N. A. , Chang , I. Y. , Muggenburg , B. A. , and
Boecker , B. B. ( 1991 ). Detection of serum alpha-fetoprotein in dogs
with hepatic tumors . J. Am. Vet. Med. Assoc. 199 , 735 – 741 .
Lurie , D. M. , Lucroy , M. D. , Griffey , S. M. , Simonson , E. , and
Madewell , B. R. ( 2004 ). T-cell-derived malignant lymphoma in the
boxer breed . Vet. Comp. Oncol. 2 , 171 – 175 .
Mahaffey , E. A. , Brown , T. P. , Duncan , J. R. , Latimer , K. S. , and
Brown , S. A. ( 1987 ). Basophilic leukaemia in a dog . J. Comp. Pathol.
97 , 393 – 399 .
Mahmoud , F. A. , and Rivera , N. I. ( 2002 ). The role of C-reactive protein
as a prognostic indicator in advanced cancer . Curr. Oncol. Rep.
4 , 245 – 250 .
Marca , M. C. , Loste , A. , Unzueta , A. , and Perez , M. ( 2000 ). Blood glycated
hemoglobin evaluation in sick dogs . Can. J. Vet. Res. 64 ,
141 – 144 .
Martin De Las Mulas , J. , Millan , Y. , Ruiz-Villamor , E. , Bautista , M. J. ,
Rollon , E. , and Espinosa De Los Monteros , A. ( 1999 ). Apoptosis and
mitosis in tumours of the skin and subcutaneous tissues of the dog .
Res. Vet. Sci. 66 , 139 – 146 .
Matos , A. J. , Faustino , A. M. , Lopes , C. , Rutteman , G. R. , and Gartner , F.
( 2006 ). Detection of lymph node micrometastases in malignant mammary
tumours in dogs by cytokeratin immunostaining . Vet. Rec. 158 ,
626 – 630 .
Mazzei , M. , Millanta , F. , Citi , S. , Lorenzi , D. , and Poli , A. ( 2002 ).
Haemangiopericytoma: histological spectrum, immunohistochemical
characterization and prognosis . Vet. Dermatol. 13 , 15 – 21 .
Medan , M. S. , Nambo , Y. , Nagamine , N. , Shinbo , H. , Watanabe , G. ,
Groome , N. , and Taya , K. ( 2004 ). Plasma concentrations of irinhibin,
inhibin A, inhibin pro-alphaC, FSH, and estradiol-17beta
during estrous cycle in mares and their relationship with follicular
growth . Endocrine 25 , 7 – 14 .